Quantcast

Latest Hypnotics Stories

2010-10-25 10:23:00

Increased Enforcement This Week as Crashes Involving Suspected Drugged Drivers on Rise HARRISBURG, Pa., Oct. 25 /PRNewswire-USNewswire/ -- PennDOT and the Pennsylvania State Police are reminding motorists that driving while under the influence of prescription and over-the-counter medication can be just as dangerous as driving under the influence of alcohol and illegal drugs. PennDOT will work with state and municipal police departments throughout Halloween week to step up...

2010-10-21 12:00:00

BURLINGTON, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next three years, Bristol Myers-Squibb/Otsuka's Abilify, and AstraZeneca's Seroquel XR will be the fastest-growing drugs in terms of prescriptions for the treatment of major depression. According to Treatment Algorithms in Major Depressive Disorder, the largest gains in market share for major depressive disorder...

2010-10-19 05:30:00

ANAHEIM, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release financial results for the third quarter ended September 30, 2010 on Thursday, October 28, 2010 after the market close. The Company will host a conference call and webcast on Thursday, October 28, 2010 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's third quarter results and current corporate developments. The dial-in number for the...

2010-10-18 23:19:00

POINT RICHMOND, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced its preliminary analysis of data from the recently completed Intermezzo® 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study. Transcept is developing Intermezzo® for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. In the...

2010-09-20 04:29:00

DALLAS, September 20, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Insomnia Market Forecast Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/33201-insomnia-market-forecast.html Search More Then 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All Datamonitor Research Reports at http://www.reportsandreports.com/Publishers/datamonitor/ The availability of...

2010-07-05 08:59:00

TEL AVIV, Israel, July 5, 2010 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.Neurim.com) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over. The approval was based primarily on data obtained in the latest SOUNDER-SLEEP Phase IV clinical study, indicating that Circadin was safe and more effective...

2010-06-07 14:03:44

When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity. In a paper published in the June Academic Emergency Medicine, UC emergency medicine assistant professor Jason McMullan, MD, found that the best means of stopping status epilepticus (SE) may be with the least direct medication. In the meta-analysis, McMullan compiled the results of six studies featuring 774 patients. His analysis...

2237edbbcbca7d3a21083dd293a43e1f1
2010-06-07 06:40:00

Individuals with chronic insomnia have an elevated risk of death, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that the adjusted hazard ratio for all-cause mortality was three times higher in people with chronic insomnia (HR = 3.0) than in people without insomnia.  When examining individual subtypes of insomnia, the risk of...

2010-04-27 13:34:00

WASHINGTON, April 27 /PRNewswire-USNewswire/ -- AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services' Health Care Fraud Enforcement Action Team (HEAT) announced today. Such unapproved uses are also known as "off-label" uses because they...

2010-04-19 08:15:00

WALTHAM, Mass., April 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018. Phase IIb trial results show significant improvement in Hamilton Depression Rating Scale scores on the effect on...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related